ConductScience.org, home

Trial · NCT00991276

Participant flow90

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Second Intervention PeriodSTARTEDPlacebo Then Pregabalin 300 mg Then Pramipexole 0.5 mg11
Second Intervention PeriodSTARTEDPramipexole 0.5 mg Then Placebo Then Pregabalin 300 mg12
Second Intervention PeriodCOMPLETEDPlacebo Then Pramipexole 0.5 mg Then Pregabalin 300 mg14
Second Intervention PeriodCOMPLETEDPramipexole 0.5 mg Then Pregabalin 300 mg Then Placebo8
Second Intervention PeriodCOMPLETEDPregabalin 300 mg Then Placebo Then Pramipexole 0.5 mg14
Second Intervention PeriodCOMPLETEDPregabalin 300 mg Then Pramipexole 0.5 mg Then Placebo9
Second Intervention PeriodCOMPLETEDPlacebo Then Pregabalin 300 mg Then Pramipexole 0.5 mg10
Second Intervention PeriodCOMPLETEDPramipexole 0.5 mg Then Placebo Then Pregabalin 300 mg11
Second Intervention PeriodNOT COMPLETEDPlacebo Then Pramipexole 0.5 mg Then Pregabalin 300 mg1
Second Intervention PeriodNOT COMPLETEDPramipexole 0.5 mg Then Pregabalin 300 mg Then Placebo2
Second Intervention PeriodNOT COMPLETEDPregabalin 300 mg Then Placebo Then Pramipexole 0.5 mg0
Second Intervention PeriodNOT COMPLETEDPregabalin 300 mg Then Pramipexole 0.5 mg Then Placebo2
Second Intervention PeriodNOT COMPLETEDPlacebo Then Pregabalin 300 mg Then Pramipexole 0.5 mg1
Second Intervention PeriodNOT COMPLETEDPramipexole 0.5 mg Then Placebo Then Pregabalin 300 mg1
Placebo Wash-out Period (7 Days)STARTEDPlacebo Then Pramipexole 0.5 mg Then Pregabalin 300 mg14
Placebo Wash-out Period (7 Days)STARTEDPramipexole 0.5 mg Then Pregabalin 300 mg Then Placebo8
Placebo Wash-out Period (7 Days)STARTEDPregabalin 300 mg Then Placebo Then Pramipexole 0.5 mg14
Placebo Wash-out Period (7 Days)STARTEDPregabalin 300 mg Then Pramipexole 0.5 mg Then Placebo9
Placebo Wash-out Period (7 Days)STARTEDPlacebo Then Pregabalin 300 mg Then Pramipexole 0.5 mg10
Placebo Wash-out Period (7 Days)STARTEDPramipexole 0.5 mg Then Placebo Then Pregabalin 300 mg11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00991276/flow?page=3